Gabriella Ferlazzo

Statistics

Publications

Citations

867

H-Index

Active since

2017

Affiliations

Médecins Sans Frontières(Current)

Médecins Sans Frontières

Instituut voor Tropische Geneeskunde

Inserm

Harvard Global Health Institute

Gabriella Ferlazzo is an author at Médecins Sans Frontières specializing in tuberculosis care, tuberculosis control, and tuberculosis pharmacotherapy.

Publications per year

2017–2025

Publications

Early safety and efficacy of the combination of bedaquiline and delamanid for the treatment of patients with drug-resistant tuberculosis in Armenia, India, and South Africa: a retrospective cohort study

Gabriella Ferlazzo, Erika Mohr-Holland, Chinmay Laxmeshwar et al. · The Lancet Infectious Diseases · 2018 · 136 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis

Lorenzo Guglielmetti, Uzma Khan, Gustavo E. Velásquez et al. · New England Journal of Medicine · 2025 · 76 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Incremental Yield of Including Determine-TB LAM Assay in Diagnostic Algorithms for Hospitalized and Ambulatory HIV-Positive Patients in Kenya

Helena Huerga, Gabriella Ferlazzo, Paolo Bevilacqua et al. · PLoS ONE · 2017 · 64 citations · Full text

Public Health, Infectious Disease Control, Infectious Diseases +17

Novel FujiLAM assay to detect tuberculosis in HIV-positive ambulatory patients in four African countries: a diagnostic accuracy study

Helena Huerga, Mathieu Bastard, Alex Vicent Lubega et al. · The Lancet Global Health · 2022 · 54 citations · Full text

Public Health, Infectious Diseases, Microbiology +17

Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis

Jay Achar, Cathy Hewison, Ana P. Cavalheiro et al. · Emerging infectious diseases · 2017 · 53 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

1–5 of 23